Jim Simons Procept Bio Robotics Corp Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 45,966 shares of PRCT stock, worth $4.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,966

Holding current value

$4.48 Million

% of portfolio

0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$45.73 - $69.19 $2.1 Million - $3.18 Million	45,966 New	45,966 $2.81 Million
Q1 2023 May 12, 2023	BUY	$26.64 - $39.74 $1.69 Million - $2.53 Million	63,566 New	63,566 $1.81 Million
Q1 2022 May 13, 2022	SELL	$16.89 - $35.74 $3.03 Million - $6.41 Million	-179,300 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$24.6 - $46.29 $4.41 Million - $8.3 Million	179,300 New	179,300 $4.48 Million

Others Institutions Holding PRCT

# of Institutions

234

Shares Held

36.6M

Call Options Held

251K

Put Options Held

101K

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $4.34B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account